All companies › SYRE

SYRE · Spyre Therapeutics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
3
Open-market sells
0
INSIDER SCANNER signals
2026-08-07
Last filing

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

SEC Form 4 filings

Every open-market transaction disclosed for SYRE in the synced window. Values are the insider's own, as filed.

DateInsiderTitleTypeSharesPriceValue
2026-08-07 Albers Jeffrey W. Director Open-market sell 5,000 104.47 $522,350
2026-08-07 Albers Jeffrey W. Director Open-market sell 8,000 104.38 $835,040
2026-08-07 Albers Jeffrey W. Director Open-market sell 10,000 104.68 $1,046,800

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.